Cutera (NASDAQ:CUTR) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research report issued on Wednesday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

Shares of CUTR stock opened at $0.43 on Wednesday. The business has a 50-day moving average of $0.40 and a 200 day moving average of $0.68. Cutera has a 1-year low of $0.28 and a 1-year high of $3.18. The stock has a market capitalization of $8.68 million, a PE ratio of -0.07 and a beta of 1.31.

Cutera (NASDAQ:CUTR) last issued its earnings results on Thursday, November 7th. The medical device company reported ($1.94) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.96) by ($0.98). The firm had revenue of $32.50 million for the quarter, compared to analysts’ expectations of $32.57 million. During the same quarter last year, the company earned ($2.22) EPS. Analysts anticipate that Cutera will post -5.78 EPS for the current year.

Institutional Investors Weigh In On Cutera

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC increased its stake in Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,964 shares of the medical device company’s stock after buying an additional 70,870 shares during the period. Squarepoint Ops LLC owned 0.57% of Cutera worth $172,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 90.70% of the company’s stock.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.